Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Shapiro J, Van Lanschot JJ, Hulshof MC, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–8.

Article  PubMed  Google Scholar 

Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593–8.

Article  CAS  PubMed  Google Scholar 

Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400–12. https://doi.org/10.1016/S0140-6736(12)60643-6.

Article  PubMed  Google Scholar 

He H, Chen N, Hou Y, Wang Z, Zhang Y, Zhang G, Fu J. Trends in the incidence and survival of patients with esophageal cancer: a SEER database analysis. Thoracic cancer. 2020;11(5):1121–8.

Article  PubMed  PubMed Central  Google Scholar 

Wu G, Yao Y, Bai C, Zeng J, Shi D, Gu X, et al. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients. Thorac Cancer. 2015;6(3):275–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim MR, Kim AS, Choi HI, Jung JH, Park JY, Ko HJ. Inflammatory markers for predicting overall survival in gastric cancer patients: a systematic review and meta-analysis. PLoS ONE. 2020;15(7):e0236445.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akgül Ö, Çetinkaya E, Yalaza M, Özden S, Tez M. Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection. World J Gastrointest Oncol. 2017;9(7):300–7.

Article  PubMed  PubMed Central  Google Scholar 

Peng H, Luo X. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis. Cancer Cell Int. 2019;19:70.

Article  PubMed  PubMed Central  Google Scholar 

Sakurai K, Ohira M, Tamura T, Toyokawa T, Amano R, Kubo N, et al. Predictive potential of preoperative nutritional status in long-term outcome projections for patients with gastric cancer. Ann Surg Oncol. 2016;23(2):525–33.

Article  PubMed  Google Scholar 

Toyokawa T, Kubo N, Tamura T, Sakurai K, Amano R, Tanaka H, et al. The pretreatment controlling nutritional status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer. 2016;16:722.

Article  PubMed  PubMed Central  Google Scholar 

Xu GW, Wu HR, Xiong R, Li CW, Liu CQ, Xu MQ, Xie MR. Value of the preoperative neutrophil-to-lymphocyte ratio as a prognostic factor for long-term survival in postoperative esophageal squamous cell carcinoma patients. Thoracic Cancer. 2018;9(12):1707–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haksoyler V, Topkan E. High pretreatment platelet-toalbumin ratio predicts poor survival results in locally advanced nasopharyngeal cancers treated with chemoradiotherapy. Ther Clin Risk Manag. 2021;17:691–700.

Article  PubMed  PubMed Central  Google Scholar 

Huang C, Xia YQ, Xiao L, Huang J, Zhu ZM. Combining the platelet-to-albumin ratio with serum and pathologic variables to establish a risk assessment model for lymph node metastasis of gastric cancer. J Biol Regul Homeost Agents. 2021;35(2):811–7.

CAS  PubMed  Google Scholar 

Huang Z, Zheng Q, Yu Y, Zheng H, Wu Y, Wang Z, et al. Prognostic significance of platelet-to albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy. Sci Rep. 2022;12(1):3535.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Saito T, Toya R, Yoshida N, Shono T, Matsuyama T, Ninomura S, et al. Spleen dose-volume parameters as a predictor of treatment-related lymphopenia during definitive chemoradiotherapy for esophageal cancer. In Vivo. 2018;32:1519–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Rossum PSN, Deng W, Routman DM, Liu AY, Xu C, Shiraishi Y, et al. Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: development and validation of a pretreatment nomogram. Pract Radiat Oncol. 2019;10:e16-26.

Article  PubMed  PubMed Central  Google Scholar 

Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, et al. Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2017;99:128–35.

Article  PubMed  Google Scholar 

Huang Z, Zheng Q, Yu Y, Zheng H, Wu Y, Wang Z, et al. Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy. Sci Rep. 2022;12(1):3535.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–81.

Article  CAS  PubMed  Google Scholar 

Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost. 2015;114(09):449–58.

Article  PubMed  Google Scholar 

Kral JB, Schrottmaier WC, Salzmann M, Assinger A. Platelet interaction with innate immune cells. Transfusion Medicine and Hemotherapy. 2016;43(2):78–88.

Article  PubMed  PubMed Central  Google Scholar 

Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells. Blood. 2005;105(1):178–85.

Article  CAS  PubMed  Google Scholar 

Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NE, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–96.

Article  CAS  PubMed  Google Scholar 

Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10(2):90–9.

Article  CAS  PubMed  Google Scholar 

Arends J. Struggling with nutrition in patients with advanced cancer: nutrition and nourishment—focusing on metabolism and supportive care. Ann Oncol. 2018;29:ii27-34.

Article  CAS  PubMed  Google Scholar 

Lindenmann J, Fink-Neuboeck N, Koesslbacher M, Pichler M, Stojakovic T, Roller RE, et al. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment. J Surg Oncol. 2014;110(6):645–50.

Article  CAS  PubMed  Google Scholar 

Sun SY, Chen PP, Meng LX, Li L, Mo ZX, Sun CH, et al. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma. Dis Esophagus. 2019;32(1):doy057.

Article  Google Scholar 

Aoyama T, Ju M, Komori K, Tamagawa H, Tamagawa A, Morita J, et al. Clinical impact of platelet-to-albumin ratio on esophageal cancer patients who receive curative treatment. In Vivo. 2022;36(4):1896–902.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Jia Y, Wang N, Zhang X, Tan B, Zhang G, et al. The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma. J Transl Med. 2014;12:1.

Article  PubMed  PubMed Central  Google Scholar 

Xu GW, Wu HR, Xiong R, Li CW, Liu CQ, Xu MQ, et al. Value of the preoperative neutrophil-to-lymphocyte ratio as a prognostic factor for long-term survival in postoperative esophageal squamous cell carcinoma patients. Thoracic Cancer. 2018;9(12):1707–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakin A, Alay M, Sahin S, Aydemir O, Aldemir MN, Sakin A, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma. North Clin Istanb. 2021;8(5):435–42.

PubMed  PubMed Central  Google Scholar 

Yang X, Huang Y, Feng JF, Liu JS. Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: a meta-analysis. Onco Targets Ther. 2015;10:789–94.

Article  Google Scholar 

Varga I, Babala J, Kachlik D. Anatomic variations of the spleen: current state of terminology, classification, and embryological background. Surg Radiol Anat. 2018;40:21–9.

Article  PubMed  Google Scholar 

Wild AT, Ye X, Ellsworth SG, Smith JA, Na